BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16898184)

  • 21. [Diverse histological lesions in a patient with antiphospholipid syndrome (APS)].
    Salvatore E; Luciani R; Di Palma A; Aversano A; Stellato D; Liuzzi M; Iele E; Martignetti V; Spagnuolo E; Morrone L
    G Ital Nefrol; 2011; 28(5):537-40. PubMed ID: 22028268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe symptomatic stenosis of visceral and renal arteries leading primary antiphospholipid syndrome diagnosis.
    Salaun E; Bartoli MA; Soler R; Khibri H; Ebbo M; Bernit E; Flavian A; Harlé JR; Magnan PE; Sarlon-Bartoli G
    Ann Vasc Surg; 2014 Oct; 28(7):1796.e9-1796.e13. PubMed ID: 24858584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moyamoya Syndrome Presenting with Ischemic Stroke Caused by Rapid Worsening of Vessel Stenosis Associated with Triple-seropositive Antiphospholipid Syndrome.
    Oura K; Yamaguchi T; Suzuki T; Yamaguchi Oura M; Itabashi R; Maeda T
    Intern Med; 2023 Mar; 62(5):793-796. PubMed ID: 35945020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Black swan in the kidney": renal involvement in the antiphospholipid antibody syndrome.
    Nzerue CM; Hewan-Lowe K; Pierangeli S; Harris EN
    Kidney Int; 2002 Sep; 62(3):733-44. PubMed ID: 12164854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Systemic lupus erythematosus and antiphospholipid syndrome].
    Gröne HJ
    Verh Dtsch Ges Pathol; 1996; 80():21-37. PubMed ID: 9065004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistant hypertension due to unilateral renal artery occlusion as the first presentation of antiphospholipid syndrome.
    Namazi MH; Khaheshi I; Serati AR; Movahed MR
    Cardiovasc Revasc Med; 2015; 16(3):190-1. PubMed ID: 25439445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertension, renal artery stenosis and the "primary" antiphospholipid syndrome.
    Asherson RA; Noble GE; Hughes GR
    J Rheumatol; 1991 Sep; 18(9):1413-5. PubMed ID: 1757947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiphospholipid syndrome: an update.
    Merashli M; Noureldine MH; Uthman I; Khamashta M
    Eur J Clin Invest; 2015 Jun; 45(6):653-62. PubMed ID: 25851448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and treatment of APS renal involvement.
    Tektonidou MG
    Lupus; 2014 Oct; 23(12):1276-8. PubMed ID: 25228725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for arterial thrombosis in antiphospholipid syndrome.
    Matyja-Bednarczyk A; Swadźba J; Iwaniec T; Sanak M; Dziedzina S; Ćmiel A; Musiał J
    Thromb Res; 2014 Feb; 133(2):173-6. PubMed ID: 24321419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
    Lopez LR; Dier KJ; Lopez D; Merrill JT; Fink CA
    Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiphospholipid syndrome and the kidneys.
    Uthman I; Khamashta M
    Semin Arthritis Rheum; 2006 Jun; 35(6):360-7. PubMed ID: 16765713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiphospholipid Syndrome and the Kidney.
    Sciascia S; Baldovino S; Schreiber K; Solfietti L; Roccatello D
    Semin Nephrol; 2015 Sep; 35(5):478-86. PubMed ID: 26573550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome.
    Krause I; Lev S; Fraser A; Blank M; Lorber M; Stojanovich L; Rovensky J; Chapman J; Shoenfeld Y
    Ann Rheum Dis; 2005 Oct; 64(10):1490-3. PubMed ID: 15778242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What nephrologists need to know about antiphospholipid syndrome.
    Alchi B; Griffiths M; Jayne D
    Nephrol Dial Transplant; 2010 Oct; 25(10):3147-54. PubMed ID: 20587422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS.
    Tektonidou MG; Sotsiou F; Moutsopoulos HM
    J Rheumatol; 2008 Oct; 35(10):1983-8. PubMed ID: 18688914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antiphospholipid syndrome and vascular disease].
    Linhartová K; Slechtová J; Simon J
    Cas Lek Cesk; 1999 Apr; 138(9):276-9. PubMed ID: 10422336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA (miRNA): A New Dimension in the Pathogenesis of Antiphospholipid Syndrome (APS).
    Kotyla PJ; Islam MA
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32197340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoimmune hemolytic anaemia in the antiphospholipid syndrome.
    Rottem M; Krause I; Fraser A; Stojanovich L; Rovensky J; Shoenfeld Y
    Lupus; 2006; 15(7):473-7. PubMed ID: 16898185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.